XML 103 R79.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Changes in Shareholders' Equity (Schedule of Activity in Shareholders' Equity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period $ 973,565 $ 967,320 $ 897,515 $ 867,543 $ 967,320 $ 867,543
Net income 24,720 27,369 26,826 27,086 52,089 53,912
Compensation and benefits paid or payable in shares 2,530 810 811 378    
Shares issued to Directors' 903   1,086      
Cumulative translation adjustments (17,653) (12,070) (2,389) 14,119    
Pension and postretirement liability adjustments 246 382 (724) (916)    
Derivative valuation adjustment (2,840) (2,124) 389 (2,902)    
Balance at end of the period $ 973,348 $ 973,565 $ 915,719 897,515 $ 973,348 $ 915,719
Dividends declared per Class A share (in dollars per share) $ 0.26   $ 0.25   $ 0.52 $ 0.50
Common Class A            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock, balance at the beginning of the period (in shares)   9,661,845     9,661,845  
Dividends declared $ (8,123) $ (8,122) $ (7,795) $ (7,792)    
Treasury stock, balance at the end of the period (in shares) 9,661,845       9,661,845  
Dividends declared per Class A share (in dollars per share) $ 0.26 $ 0.26 $ 0.25 $ 0.25    
Common Stock | Common Class A            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock, balance at the beginning of the period (in shares) 40,898,000 40,856,000 40,842,000 40,785,000 40,856,000 40,785,000
Balance at start of the period $ 41 $ 41 $ 41 $ 41 $ 41 $ 41
Compensation and benefits paid or payable in shares (in shares)   42,000   58,000    
Shares issued to Directors' (in shares) 10,000          
Common stock, balance at the end of the period (in shares) 40,908,000 40,898,000 40,842,000 40,842,000 40,908,000 40,842,000
Balance at end of the period $ 41 $ 41 $ 41 $ 41 $ 41 $ 41
Additional paid-in capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period 449,028 448,218 441,917 441,540 448,218 441,540
Compensation and benefits paid or payable in shares 2,530 810 811 378    
Shares issued to Directors' 903   828      
Balance at end of the period 452,461 449,028 443,556 441,917 452,461 443,556
Retained  earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period 1,030,111 1,010,942 950,415 931,318 1,010,942 931,318
Net income 24,624 27,291 26,672 26,889    
Balance at end of the period 1,046,612 1,030,111 969,292 950,415 1,046,612 969,292
Retained  earnings | Common Class A            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends declared (8,123) (8,122) (7,795) (7,792)    
Accumulated items of other comprehensive income            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period (147,026) (133,168) (134,864) (144,927) (133,168) (144,927)
Cumulative translation adjustments (17,287) (12,116) (2,568) 13,881    
Pension and postretirement liability adjustments 246 382 (724) (916)    
Derivative valuation adjustment (2,840) (2,124) 389 (2,902)    
Balance at end of the period (166,907) (147,026) (137,767) (134,864) (166,907) (137,767)
Treasury Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period $ (364,665) $ (364,665) $ (364,923) $ (364,923) $ (364,665) $ (364,923)
Treasury stock, balance at the beginning of the period (in shares) 9,662,000 9,662,000 9,675,000 9,675,000 9,662,000 9,675,000
Shares issued to Directors' (in shares)     (12,000)      
Shares issued to Directors'     $ 258      
Balance at end of the period $ (364,665) $ (364,665) $ (364,665) $ (364,923) $ (364,665) $ (364,665)
Treasury stock, balance at the end of the period (in shares) 9,662,000 9,662,000 9,663,000 9,675,000 9,662,000 9,663,000
Noncontrolling Interest            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at start of the period $ 6,076 $ 5,952 $ 4,929 $ 4,494 $ 5,952 $ 4,494
Net income 96 78 154 197    
Cumulative translation adjustments (366) 46 179 238    
Balance at end of the period $ 5,806 $ 6,076 $ 5,262 $ 4,929 $ 5,806 $ 5,262